Merck, Schering-Plough results get boost from cholesterol drugs

Article Abstract:

Merck and Company Inc. of the United States net profit soared in the second quarter and financial projections for the year were raised. Revenues were buoyed by increased sales of cholesterol drugs. Financial projections may be affected by generic knock offs of the cholesterol drug Zocor.

Merck & Company Inc., Company overview

---

Lilly posts profit drop on charges, lifts outlook

Article Abstract:

First-quarter profits for pharmaceutical firm Eli Lilly and Co. fell 39% primarily due to lawsuit settlements and drug-pipeline obstructions; however, revenue increased by 14% for impotence and antipsychotic agents. The firm has raised its full-year outlook.

Eli Lilly and Co., LLY, Financial report

---

Amgen's net income rises 20%; new drugs help Lilly post profit

Article Abstract:

Amgen Inc. of the United States posted strong earnings in the fourth quarter with net income increasing 20 percent to $824 million. Revenue is up 12 percent to $3.27 billion. Strong earnings are projected for 2006.

Industry Overview, Company Profile, Amgen Inc., AMGN

Similar abstracts:

• Abstracts: Glaxo aims to boost prospects of four promising cancer drugs. Britain stirs outcry by weighing benefits of drugs versus price
• Abstracts: Making dough on the net. As good as their word. Making pain pay
• Abstracts: School of ads. Business gets personal. Promoting out-of-home
• Abstracts: GRP boats get larger. Netmaker regroups at former shipyard. Back in the door business!
• Abstracts: Tasa's Pisco factory lights up night sky. $1m Russian sales for new trawl firm. Deepsea giant moves inshore

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.